Squamous Cell Carcinoma of Unknown Primary Origin
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma of Unknown Primary Origin.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-07-19Clinical Trial Update: Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating ficlatuzumab with or without cetuximab in cetuximab-resistant recurrent or metastatic head and neck squamous cell c…